CEO, ONCOCYTE
WHY: Heads Irvine-based cancer diagnostics company, which had 124 employees as of June.
IN THE NEWS: Moved Oncocyte from Alameda to Irvine in 2020. Oncocyte (NYSE: OCX) ranked No. 3 on the Business Journal’s 2022 Best Places to Work list, in the category of Midsize companies.
QUOTABLE: “We are together in the fight against cancer. Each person matters and we celebrate what makes each one of us unique and our individual gifts that we bring to the table. There’s probably no one I know that’s more than one degree removed from cancer.”
